Endocrinologist Japan Drugs in the 2026 list Related insights Blog July 2, 2024 What GLP-1 drugs mean for medtech Are the powerful weight loss and diabetes treatments a lose-lose for medical technology companies
In some instances, addition of an auris-compatible dye to an otic formulation or composition described herein aids visualization of any administered formulation or composition in an ear (e.g., a rodent ear and/or a human ear)
Yamaura K, Ogawa K, Yonekawa T, Nakamura T, Yano S, Ueno K
study revealed that cabergoline (CAB) treatment in men with hyperprolactinemia improves their metabolic profile and reduces the incidence of MS
Since that time Ive lost seven lbs
SAGs enhanced stability profile may contribute to extended shelf life compared to unmodified GSH, depending on specific formulation and storage conditions